LifeVantage Reports Full Clinical Results Including Average of 140% Increase in GLP-1 with the MindBody GLP-1 System™Ω
The 12-week human clinical trial began in early June 2024 and set out to investigate if, through these mechanisms of action, ...
Clinical guidance says most patients can continue GLP-1 anti-obesity drugs before surgery
Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing ...
Ars Live: What else can GLP-1 drugs do? Join us today for a discussion.
News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...
Medscape1d
GLP-1 RAs Reduce Early-Onset Colorectal Cancer Risk in Patients With Type 2 Diabetes
A large retrospective study, the first of its kind, reported reduced rates of EO-CRC in patients younger than 50 years of age ...
Rolling Out4d
GLP-1 boosting foods with 7 powerful ways to enhance your production
When food enters the digestive system, specialized cells in the small intestine release GLP-1, initiating a cascade of ...
STAT7d
More state Medicaid programs consider covering GLP-1 drugs
While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...
HealthDay on MSN2d
GIP/GLP-1 RA Beneficial for Patients With Opioid, Alcohol Use Disorder
For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 ...
MedPage Today11h
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients
Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from several medical societies, including the American Society of ...